| Bioactivity | Aspirin DL-lysine (ASA DL-lysine) is a lysine-containing aspirin derivative. Aspirin DL-lysine inhibits cyclooxygenase (COX) in platelets, blocks the synthesis of thromboxane A2 (TXA2), and thus inhibits platelet aggregation and activation. Aspirin DL-lysine can be used to study thrombin generation in patients with unstable angina pectoris[1]. |
| CAS | 62952-06-1 |
| Formula | C15H22N2O6 |
| Molar Mass | 326.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Yasu T, et al. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris[J]. The American journal of cardiology, 1993, 71(13): 1164-1168. |
Aspirin DL-lysine
CAS: 62952-06-1 F: C15H22N2O6 W: 326.34
Aspirin DL-lysine (ASA DL-lysine) is a lysine-containing aspirin derivative. Aspirin DL-lysine inhibits cyclooxygenase (
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.